Catalyst Wire Dossier Catalyst Wire Dossier

Amlodipine and olmesartan medoxomil

amlodipine and olmesartan medoxomil · ScieGen Pharmaceuticals, Inc
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Amlodipine and olmesartan medoxomil, covering 2016-10-26 to 2025-02-14. Get the full timeline:

Most recent: FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Original Application (Camber Pharmaceuticals, Inc.)

See pricing